Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BRS YR2 > Lung Cancer > Flashcards

Lung Cancer Flashcards

1
Q

How common is lung cancer?

A
  • 3rd most common (UK)

- leading cause of death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is most likely to have lung cancer?

A
  • 75-90yrs old
  • males
  • low socioeconomic status
  • smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes of lung cancer?

A
  • smoking
  • passive smoking
  • asbestos (x2)
  • radon
  • indoor cooking fumes
  • chronic lung disease (COPD, Fibrosis)
  • Immunodeficiency
  • genetics/family history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 different types of lung cancer?

A
  • squamous cell carcinoma
  • adenocarcinoma
  • large cell lung cancer
  • small cell lung cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is squamous cell carcinoma?

A
  • 30% of cases
  • originates @ bronchial epithelium
  • centrally located
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is adenocarcinoma?

A
  • 40% of cases
  • possible link to tar cigarettes
  • originates from mucus producing glandular tissue
  • located peripherally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is large cell lung carcinoma?

A
  • 15%
  • heterogenous group
  • undifferentiated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is small cell lung cancer?

A
  • 15%
  • originates at pulmonary neuroendocrine cells
  • highly malignant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What cancers make up Non-Small Cell Lung Cancer?

A
  • squamous cell carcinoma
  • adenocarcinoma
  • large cell lung cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What histology can be seen in early lung cancer development?

A

hyperplasia, followed by squamous metaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What histology can be seen in intermediate lung cell cancer development?

A

dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What histology can be seen in late lung cell cancer development?

A

carcinoma in situ followed by an invasive carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is metaplasia?

A

reversible change in which one adult cell type replaced by another adult cell type; adaptive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is dysplasia?

A

abnormal pattern of growth in which some of the cellular and architectural features of malignancy are present; pre-invasive stage with INTACT basement membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an oncogene?

A

genetic mutations that predisposes someone to a particular cancer, important to inform treatment/prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is impact of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase mutation?

A 
- 15-30% adenocarcinoma
seen in:
- women 
- asian ethnicity
- never-smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the impact of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase mutation?

A
  • 2-7% of non-small cell lung cancer
    seen in:
  • youth
  • never-smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the impact of a mutation in c-ROS Oncogene 1 (ROS-1) Receptor Tyrosine Kinase?

A
  • 1-2% of non-small cell lung cancer
    seen in:
  • youth
  • never-smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the impact of a mutation in BRAF (downstream cell-cycle signalling mediator)?

A
  • 1-3% of non-small cell lung cancer
    seen in:
  • smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the key symptoms of lung cancer?

A
  • cough
  • weight loss
  • breathlessness
  • fatigue
  • chest pain
  • haemoptysis
    OFTEN ASYMPTOMATIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the features of advanced/metastatic disease?

A 
neurological features
- focal weakness
- seizures
- spinal cord compression
bone pain 
paraneoplastic syndromes:
- clubbing 
- hypercalcaemia
- hyponatraemia
- cushing's
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the common signs seen with lung cancer?

A
  • clubbing
  • cachexia
  • Horner’s syndrome
  • Pemberton’s sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is Pemberton’s sign?

A

Superior vena cava obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is Horner’s syndrome?

A
  • contracted pupil
  • drooping upper eyelid
  • loss of sweating on one side of the face
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the most useful form of imaging to see occult metastases?

A

PET scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What types of imaging are used to diagnose lung cancer?

A
  • Chest x-ray
  • Staging CT (chest+abdomen)
  • PET scan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When should a bronchoscopy be used in lung cancer?

A
  • tumours of the central airway

- no need for tissue staging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the method of a primary biopsy?

A

Choose based on:

  • accessibility
  • availability
  • impact on staging
29
Q

What is the aim of an Endobronchial US and Transbronchial-needle aspiration of the mediastinal lymph nodes?

A

stage mediastinum +/- achieve tissue diagnosis

30
Q

Why would you do a CT-guided lung biopsy?

A

to access peripheral lung tumours

31
Q

What does T1-4 represent in staging?

A

tumour size and location

32
Q

What does N0-3 represent in staging?

A

lymph node involvement - mediastinum and beyond

33
Q

What does M0-1c represent in staging?

A

metastases and the number of them

34
Q

What are the determinants of treatment?

A
  • patient fitness
  • cancer histology
  • cancer stage
  • patient preference
  • health service factors
35
Q

What are the different classifications in the WHO performance status?

A

0 - Asymptomatic
1 - Symptomatic, completely ambulatory
2 - symptomatic, <50% in bed during the day
3 - symptomatic, >50% in bed, not bedbound
4 - bedbound
5 - death

36
Q

Which WHO performance statuses is radical treatment restricted to?

A

PS 0-2

37
Q

What should also be taken into account with the WHO performance status?

A
  • comorbidity

- lung function

38
Q

What is the standard of care for early stage lung cancer?

A
  • surgical resection

- radiotherapy with curative intent

39
Q

What is the most common surgical resection done in lung cancer?

A
  • lobectomy

(+/-) lymphandectomy

40
Q

What is the surgical resection done if the cancer is stage I (= 3cm)?

A

sublobar resection

41
Q

What is a wedge resection?

A

removal of a small part of the lung

tumour + a margin of healthy tissue

42
Q

What is a segmental resection?

A

removing a large part of the lung, but NOT an entire lobe

43
Q

What is a lobectomy?

A

removal of an entire lobe of the lung

44
Q

What is a pneumonectomy?

A

removal of an entire lung.

45
Q

What is an alternative to surgery for early stage lung cancer due to comorbidities?

A

radical radiotherapy

46
Q

What is Radical Radiotherapy?

A

Stereotactic Ablative Body Radiotherapy (SABR)

  • high precision targeting
  • multiple, convergent beams
47
Q

What is the first line treatment for metastatic non-small cell lung cancer with mutation?

A

Oncogene-directed treatments

48
Q

What is treatment of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase mutation?

A
  • erlotinib
  • gefitinib
  • afatinib
  • dacomitinib
  • osimertinib
49
Q

What is the treatment of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase mutation?

A
  • crizotinib
  • ceritinib
  • alectinib
  • brigatinib
  • lorlatinib
50
Q

What is the treatment of a mutation in c-ROS Oncogene 1 (ROS-1) Receptor Tyrosine Kinase?

A
  • cirzotinib

- entrectinib

51
Q

What is the efficacy of oncogene-directed treatment?

A
  • increase progression-free survival

- no increase in overall survival when compared to chemotherapy

52
Q

What are the side effects on oncogene-directed treatment?

A
  • well tolerated (tablets)
  • rash
  • diarrhoea
    UNCOMMON:
  • pneumonitis
53
Q

How does immunotherapy to treat lung cancer work?

A

blocks PD-L1/PD-1 to allow T-cell killing of the cell

54
Q

What is the first line treatment for NSCLC with NO mutation (PDL1>50%)?

A

immunotherapy

  • prembrolizumab
  • atezolizumab
  • nivolumab
55
Q

What is the efficacy of immunotherapy?

A

greater progression-free survival and overall survival in comparison to chemotherapy

56
Q

What are the side effects of immunotherapy?

A
  • well tolerated

- (10-15%) immune-related side effects (thyroid, skin, bowel, lung and liver)

57
Q

What is the first line treatment for metastatic NSCLC with NO mutation and PDL<50%?

A

cytotoxic chemotherapy

+ immunotherapy

58
Q

What is cytotoxic chemotherapy?

A
  • targets rapidly dividing cells
  • long established
  • paltinum-based regimens (carboplatin, cisplatin, paclitaxel, premetrexed)
59
Q

What is the efficacy of cytotoxic chemotherapy?

A

alone:
modest survival improvements
w/ immunotherapy (pembrolizumab):
significantly better

60
Q

What are the side effects of cytotoxic chemotherapy?

A
  • fatigue
  • nausea
  • bone marrow suppression
  • nephrotoxicity
61
Q

What is palliative and supportive care?

A
  • symptom control
  • psychological support
  • education
  • practical and financial support
  • end-of-life planning
62
Q

When is palliative care given?

A

all patients with advanced stage disease

63
Q

What is key for successful palliative care?

A

lung cancer specialist nurses

64
Q

What is the impact of palliative care (+standard oncology care)?

A
  • improved quality of life
  • lower depression scores
  • increased survival (2.5 months)
65
Q

What is the expected treatment of locally advanced treatment (involving thoracic lymph nodes)?

A
  • surgery and adjuvant chemotherapy

- radiotherapy and chemotherapy (+/- immunotherapy)

66
Q

What is the treatment for metastatic lung disease with a targetable mutation?

A
  • tyrosine kinase inhibitor

- palliative care

67
Q

What is the treatment for metastatic lung disease with NO mutation, PDL-1 positive (>50%)?

A
  • immunotherapy, ALONE

- palliative care

68
Q

What is the treatment for metastatic lung disease with NO mutation, PDL-1 negative (<50%)?

A
  • immunotherapy + chemotherapy

- palliative care

69
Q

What is the prognosis of lung cancer?

A

only 10% live longer than 10 years

BRS YR2 (70 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions